Inhaltsbereich
| 111 Einträge | 1, 2, 3, 4, 5, 6 › » |
Seite 1 / 6
 Druckansicht
|
| Activity of T-DM1 in Her2-positive breast cancer brain metastases. |
| Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Dubsky P, Dieckmann K, Pinker K, Bago-Horvath Z, Galid A, Oehler L, Zielinski CC, Gnant M, Steger GG, Preusser M |
| Clinical & experimental metastasis. 2015 Aug 25. doi: 10.1007/s10585-015-9740-3 |
| PMID: 26303828 |
| Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy. |
| Promberger R, Dubsky P, Mittlböck M, Ott J, Singer C, Seemann R, Exner R, Panhofer P, Steger G, Bergen E, Gnant M, Jakesz R, Bago-Horvath Z, Rudas M, Bartsch R |
| Clinical breast cancer. 2015 Jun 18. pii: S1526-8209(15)00123-8. doi: 10.1016/j.clbc.2015.06.007 |
| PMID: 26195436 |
| Diagnostic accuracy of (18)F-FDG PET/CT compared with that of contrast-enhanced MRI of the breast at 3 T. |
| Magometschnigg HF, Baltzer PA, Fueger B, Helbich TH, Karanikas G, Dubsky P, Rudas M, Weber M, Pinker K |
| European journal of nuclear medicine and molecular imaging. 2015 Jun 30. doi: 10.1007/s00259-015-3099-1 |
| PMID: 26121928 |
| TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family. |
| Kappel S, Janschek E, Wolf B, Rudas M, Teleky B, Jakesz R, Kandioler D |
| Breast cancer research and treatment. 2015 May 16. doi: 10.1007/s10549-015-3424-1 |
| PMID: 25981898 |
| Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype. |
| Gnant M, Sestak I, Filipits M, Dowsett M, Balic M, Lopez-Knowles E, Greil R, Dubsky P, Stoeger H, Rudas M, Jakesz R, Ferree S, Cowens JW, Nielsen T, Schaper C, Fesl C, Cuzick J |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 1. pii: mdv215. doi: 10.1093/annonc/mdv215 |
| PMID: 25935792 |
| The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial. |
| Fitzal F, Filipits M, Rudas M, Greil R, Dietze O, Samonigg H, Lax S, Herz W, Dubsky P, Bartsch R, Kronenwett R, Gnant M |
| British journal of cancer. 2015 Mar 24. pii: bjc201598. doi: 10.1038/bjc.2015.98. pmc: PMC4402462 |
| PMID: 25867274 |
| Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer. |
| Bergen E, Berghoff AS, Rudas M, Dubsky P, De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal F, Gnant M, Rottenfusser A, Zielinski CC, Preusser M, Steger GG, Bartsch R |
| Breast care (Basel, Switzerland). 2015 Mar 11. doi: 10.1159/000368330. pii: brc-0009-0344. pmc: PMC4322687 |
| PMID: 25759615 |
| Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study. |
| Pinker K, Baltzer P, Bogner W, Leithner D, Trattnig S, Zaric O, Dubsky P, Bago-Horvath Z, Rudas M, Gruber S, Weber M, Helbich TH |
| Radiology. 2015 Mar 4. doi: 10.1148/radiol.15141905 |
| PMID: 25751227 |
| Breast cancer brain metastases responding to lapatinib plus capecitabine as second-line primary systemic therapy. |
| Bergen ES, Berghoff AS, Rudas M, Preusser M, Bartsch R |
| Anti-cancer drugs. 2015 Apr 2. doi: 10.1097/CAD.0000000000000217 |
| PMID: 25714248 |
| Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. |
| Riedl CC, Luft N, Bernhart C, Weber M, Bernathova M, Tea MK, Rudas M, Singer CF, Helbich TH |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Feb 23. pii: JCO.2014.56.8626. doi: 10.1200/JCO.2014.56.8626 |
| PMID: 25713430 |
| Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. |
| Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P |
| Breast (Edinburgh, Scotland). 2014 Jul 10. pii: S0960-9776(14)00124-6. doi: 10.1016/j.breast.2014.06.011 |
| PMID: 25017122 |
| The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer. |
| Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retèl VP, Fitzal F, Rudas M, Singer C, Pfeiler G, Gnant M, Jakesz R, Dubsky P |
| British journal of cancer. 2014 Jul 8. pii: bjc2014339. doi: 10.1038/bjc.2014.339. pmc: PMC4150264 |
| PMID: 25003667 |
| Antiestrogenic effects of the fetal estrogen estetrol in women with estrogen-receptor positive early breast cancer. |
| Singer CF, Bennink HJ, Natter C, Steurer S, Rudas M, Moinfar F, Appels N, Visser M, Kubista E |
| Carcinogenesis. 2014 Jul 5. pii: bgu144. doi: 10.1093/carcin/bgu144 |
| PMID: 24997853 |
| Alleviation of brain edema and restoration of functional independence by bevacizumab in brain-metastatic breast cancer: a case report. |
| Berghoff AS, Sax C, Klein M, Furtner J, Dieckmann K, Gatterbauer B, Widhalm G, Rudas M, Zielinski CC, Bartsch R, Preusser M |
| Breast care (Basel, Switzerland). 2014 Jun 19. doi: 10.1159/000360930. pii: brc-0009-0134. pmc: PMC4038309 |
| PMID: 24944558 |
| MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies. |
| Spick C, Pinker-Domenig K, Rudas M, Helbich TH, Baltzer PA |
| European radiology. 2014 Apr 5. doi: 10.1007/s00330-014-3153-6 |
| PMID: 24706105 |
| The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer. |
| Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M |
| Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Feb 11. pii: 1078-0432.CCR-13-1845. doi: 10.1158/1078-0432.CCR-13-1845 |
| PMID: 24520097 |
| Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). |
| Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt508. doi: 10.1093/annonc/mdt508 |
| PMID: 24347519 |
| Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. |
| Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, Fesl C, Nielsen TO |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt494. doi: 10.1093/annonc/mdt494 |
| PMID: 24347518 |
| The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients. |
| Dubsky P, Brase JC, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Fisch K, Kronenwett R, Gnant M, Filipits M |
| British journal of cancer. 2013 Oct 24. pii: bjc2013671. doi: 10.1038/bjc.2013.671. pmc: PMC3859949 |
| PMID: 24157828 |
| Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions. |
| Pinker K, Bickel H, Helbich TH, Gruber S, Dubsky P, Pluschnig U, Rudas M, Bago-Horvath Z, Weber M, Trattnig S, Bogner W |
| European radiology. 2013 Mar 16. doi: 10.1007/s00330-013-2771-8 |
| PMID: 23504036 |
| 111 Einträge | 1, 2, 3, 4, 5, 6 › » |
Seite 1 / 6
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
